Sarepta Therapeutics
SRPT
$119.70
Share price
-0.62%
Change (1 day)
24.54%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Sarepta Therapeutics (SRPT) - Cash on Hand
Cash on Hand as of June 2023 : $1.86 B
According to Sarepta Therapeutics
's latest financial reports the company has $1.86 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sarepta Therapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $1.98 B | -5.98% |
| 2021-12-31 | $2.11 B | 9.15% |
| 2020-12-31 | $1.93 B | 72.36% |
| 2019-12-31 | $1.12 B | -4.19% |
| 2018-12-31 | $1.17 B | 8.79% |
| 2017-12-31 | $1.07 B | 239.49% |
| 2016-12-31 | $0.31 B | 65.12% |
| 2015-12-31 | $0.19 B | -8.49% |
| 2014-12-31 | $0.21 B | -18.14% |
| 2013-12-31 | $0.25 B | 36.93% |
| 2012-12-31 | $0.18 B | 370.28% |
| 2011-12-31 | $39.9 M | 18.8% |
| 2010-12-31 | $33.58 M | -30.67% |
| 2009-12-31 | $48.44 M | 322.21% |
| 2008-12-31 | $11.47 M | -54.24% |
| 2007-12-31 | $25.07 M | -24.37% |
| 2006-12-31 | $33.15 M | -29.54% |
| 2005-12-31 | $47.05 M | 141.1% |
| 2004-12-31 | $19.51 M | -48.1% |
| 2003-12-31 | $37.59 M | 94.88% |
| 2002-12-31 | $19.29 M | -24.63% |
| 2001-12-31 | $25.59 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $8.00 B | 329.99% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $0.33 B | -81.84% | 🇺🇸 USA |
 Novavax NVAX | $0.50 B | -72.81% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $2.05 B | 10.58% | 🇺🇸 USA |
 Insmed INSM | $0.91 B | -50.68% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.41 B | -77.74% | 🇺🇸 USA |
 Avidity Biosciences RNA | $0.57 B | -69.02% | 🇺🇸 USA |